Literature DB >> 21981815

Extracorporeal shock wave lithotripsy with a transportable mini-lithotripter and subsequent endoscopic treatment improves clinical outcome in obstructive calcific chronic pancreatitis.

Vladan Milovic1, Till Wehrmann, Christoph F Dietrich, Adam A Bailey, Wolfgang F Caspary, Barbara Braden.   

Abstract

BACKGROUND: Extracorporeal shock wave lithotripsy (ESWL) of pancreatic duct stones followed by ERCP with mechanical clearance of the pancreatic duct and subsequent stenting is an established treatment option for chronic calcific pancreatitis.
OBJECTIVE: To test the efficacy of a modified transportable mini-lithotripter for ESWL of pancreatic duct stones.
DESIGN: Prospective single-center study.
SETTING: University hospital. PATIENTS: This study involved 32 patients with obstructive chronic calcific pancreatitis and pain in whom previous endoscopic stone removal and pancreatic duct decompression had failed.
INTERVENTIONS: ESWL followed by ERCP for stone clearance of the pancreatic duct and mechanical removal of stones or stenting. MAIN OUTCOME MEASUREMENTS: Endoscopic duct clearance and/or stent insertion, pain and quality-of-life scores.
RESULTS: A median of 4 ESWL sessions (interquartile range 2.75-8.5) with a median of 6800 shock waves (4225-15,425) were required. Pain relief after ESWL only was noted in 24 patients (75.0%), whereas no change in the intensity of pain was reported by 7 patients (21.9%), and pain was worse in 1 patient. All patients underwent ERCP and stent placement, resulting in complete resolution of pain in 17 patients (53.1%) and pain improvement in 28 patients (87.5%). The quality-of-life score was significantly improved after ESWL and endoscopic clearance or stenting in all patients. LIMITATIONS: Uncontrolled study.
CONCLUSIONS: ESWL with the mini-lithotripter results in fragmentation of pancreatic duct calculi. ESWL in conjunction with endoscopic clearance of the pancreatic duct and stenting is associated with significant improvement in clinical outcome and quality of life in patients with obstructive calcific chronic pancreatitis.
Copyright © 2011 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21981815     DOI: 10.1016/j.gie.2011.07.062

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  5 in total

1.  Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report.

Authors:  Müjde Soytürk; Göksel Bengi; Dilek Oğuz; İsmail Hakkı Kalkan; Mehmet Yalnız; Mustafa Tahtacı; Kadir Demir; Elmas Kasap; Nevin Oruç; Nalan Gülşen Ünal; Orhan Sezgin; Osman Özdoğan; Engin Altıntaş; Serkan Yaraş; Erkan Parlak; Aydın Şeref Köksal; Murat Saruç; Hakan Ünal; Belkıs Ünsal; Süleyman Günay; Deniz Duman; Alper Yurçi; Sabite Kacar; Levent Filik
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.555

Review 2.  Management of Pancreatic Calculi: An Update.

Authors:  Manu Tandan; Rupjyoti Talukdar; Duvvur Nageshwar Reddy
Journal:  Gut Liver       Date:  2016-11-15       Impact factor: 4.519

3.  Drainage procedure for pancreatolithiasis: re-examination of the pancreatic duct diameter standard.

Authors:  Guoyong Chen; Yu You; Hongxian Yan; Junchuang He; Jianping Gong; Sidong Wei
Journal:  Ann Surg Treat Res       Date:  2020-03-31       Impact factor: 1.859

4.  Process improvement for a complex dual medical procedure.

Authors:  Wade Anthony Weigel; Michael Gluck; Andrew S Ross; Otto S Lin; Barbara L Williams; Craig C Blackmore
Journal:  BMJ Open Qual       Date:  2018-08-21

5.  Serine Protease Inhibitor Kazal Type 1 (SPINK1) c.194+2T > C Mutation May Predict Long-term Outcome of Endoscopic Treatments in Idiopathic Chronic Pancreatitis.

Authors:  Chang Sun; Mu-Yun Liu; Xiao-Gang Liu; Liang-Hao Hu; Tian Xia; Zhuan Liao; Zhao-Shen Li
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.